You can say our faculty 'wrote the book' on pediatric blood disorders. Because of our long track record of innovation, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is considered a world leader in laboratory and clinical research on blood disorders. We discovered two white blood cell disorders, Shwachman-Diamond syndrome and Diamond-Blackfan syndrome, and we developed the first test to detect prenatal thalassemia. We are a world leader in research on platelet disorders and immune thrombocytopenia.
Members of our Blood Disorders Center:
Currently, our Blood Disorders Center is investigating the possible use of genetic therapy to cure sickle cell disease, anemia, hemophilia, and other conditions, studying the molecular basis of Fanconi anemia, and conducting research to improve the quality of life of children with blood disorders. Learn how tomorrow's breakthroughs are being developed today through our ongoing clot disorder clinical trials.
Rated the top pediatric cancer center by U.S. News & World Report